WAVEMAN · COMPANY

CHD · Church & Dwight Co Inc /De/

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

CHD

Name: CHURCH & DWIGHT CO INC /DE/ (CHD) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

CHURCH & DWIGHT CO INC /DE/

PHARMA & BIOTECH · SOAP, DETERGENTS, CLEANG PREPARATIONS, PERFUMES, COSMETICS · CIK 0000313927

FORM 144 · 4☆ WATCH

INSIDER NET · 180D

-$10.8M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

478

13F, latest reported quarter

REVENUE GROWTH

+1.6%

XBRL, annual

NET MARGIN

11.9%

CONVERSIONS · 180D

codes C/M, not in net · $5.7M priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$10.8M over 180 days

-$9.6M over 90 days

below 85% of Pharma & Biotech

CONGRESS

no member of Congress has reported trading it

FUNDS

478 funds added or opened last quarter

more than 96% of Pharma & Biotech

REVENUE

+1.6% year over year

below 51% of Pharma & Biotech

MARGIN

11.9% net margin

more than 83% of Pharma & Biotech

BUYBACKS

$900.0M repurchased, FY to 2025-12-31

more than 93% of Pharma & Biotech

SHORT

4.4% of shares outstanding short · 5.4 days to cover · settled 2026-07-31

more than 50% of Pharma & Biotech

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

Insiders are net sellers: -$10.8M across 8 people in 180 days.

478 funds added or opened positions in the latest 13F quarter, of 1,073 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +7.1%

+7.1%12M

INSIDER SELLFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders have filed to sell — before selling.

The record shows a net $10.8M sold by insiders over 180 days, 478 funds added last quarter, $5.4M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, CHURCH & DWIGHT CO INC /DE/ insiders sold a net $10.8M of stock across 129 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

Linares Carlos G.

EVP Chief Tech&Global New Prod

SELL

2026-08-26

15,375.0

$1.6M

Hemsey Rene

EVP, Chief HR Officer

SELL

2026-08-25

5,000.0

$511.3K

Linares Carlos G.

EVP Chief Tech&Global New Prod

SELL

2026-08-24

15,375.0

$1.6M

IRWIN BRADLEY C

Director

SELL

2026-08-11

4,300.0

$441.6K

WINKLEBLACK ARTHUR B

Director

SELL

2026-08-05

13,200.0

$1.4M

129 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 124 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

22,445,656.0 sh

$2.2B

VANGUARD CAPITAL MANAGEMENT LLC

15,505,024.0 sh

$1.5B

STATE STREET CORP

14,048,326.0 sh

$1.4B

VANGUARD PORTFOLIO MANAGEMENT LLC

13,159,991.0 sh

$1.3B

JPMORGAN CHASE & CO

9,140,532.0 sh

$894.9M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

Rene Hemsey

FILED 2026-08-25

$506.5K

Carlos Linares

FILED 2026-08-13

$3.1M

Bradley Irwin

FILED 2026-08-11

$441.2K

Arthur Winkleblack

FILED 2026-08-05

$1.4M

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Invesco Dorsey Wright Consumer Staples Momentum ETF

$4.3M POSITION · AS OF 2026-04-30

5.1%

PAPP SMALL & MID-CAP GROWTH FUND

$1.8M POSITION · AS OF 2026-02-28

3.9%

Fundsmith Equity ETF

$528.3K POSITION · AS OF 2026-03-31

3.9%

Geneva SMID Cap Growth Fund

$1.4M POSITION · AS OF 2026-02-28

3.0%

Jensen Quality Mid Cap Fund

$3.6M POSITION · AS OF 2026-02-28

2.9%

Guardian Mid Cap Relative Value VIP Fund

$2.5M POSITION · AS OF 2026-03-31

2.8%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Clinical pipeline

ClinicalTrials.gov · 15 registered trials, 0 still enrolling or running — a status change here is dated weeks before the press release

Not applicable

0 ACTIVE

TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED

Executive pay vs shareholder return · Mr. Farrell

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2020

$9.9M

$22.8M

$2.0M

+25%

+16%

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$6.2B	$6.1B	$5.9B	$5.4B
GROSS PROFIT	$2.8B	$2.8B	$2.6B	$2.2B
OPERATING INCOME	$1.1B	$807.1M	$1.1B	$597.8M
NET INCOME	$736.8M	$585.3M	$755.6M	$413.9M
EPS (DILUTED)	3.02	2.37	3.05	1.68
OPERATING CASH FLOW	$1.2B	$1.2B	$1.0B	$885.2M
CASH	$409.0M	$964.1M	$344.5M	$270.3M
LONG-TERM DEBT	$2.2B	$2.2B	$2.2B	$2.6B
BUYBACKS	$900.0M	$0	$300.1M	$0
DIVIDENDS PAID	$287.2M	$277.0M	$266.5M	$255.0M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE